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ABSTRACT
Some retinoids show an anti-inflammatory action
through regulation of transcription of various genes. In
the present study, the inhibitory effect of 4-( (5,6,7,8-
tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carbamoyl)
benzoic acid (Am-80), a synthetic retinoid, on mouse
contact hypersensitivity provoked by repeated applica-
tions of 2,4-dinitrofluorobenzene (DNFB) to the ear
was investigated. Five-fold applications of DNFB on
ears once per week elicited severe contact dermatitis
with marked infiltration of inflammatory cells and ele-
vation of anti-dinitrophenyl (DNP)-IgE antibody in the
serum. The Am-80 significantly inhibited ear swelling
in a dose-dependent manner. In the histopathologic
study, infiltration of inflammatory cells was clearly
decreased by Am-80. However, Am-80 did not affect
the production of DNP-specific IgE antibody both at the
transcriptional and post-transcriptional levels. The
effects of Am-80 on the transcriptional level of
cytokines, interferon (IFN)-g , interleukin (IL)-1 and IL-4
in cervical lymph nodes were investigated. Marked
elevation of mRNA for all cytokines was observed and
Am-80 potently inhibited the expression of IFN-g
mRNA, but not IL-1 and IL-4 mRNA. These findings
indicated that Am-80 may inhibit the contact dermatitis
at the post-sensitization phase by inhibiting IFN- g 
production at the transcriptional level in mice.
Key words: 2,4-dinitrofluorobenzene, Am-80, contact
dermatitis, cytokine, retinoid.
INTRODUCTION
The skin is an important immunologic tissue and acts as
the first barrier to protect against invasive factors, includ-
ing viruses, chemicals and insects. The inflammatory
stimulus, which results from exposure to a variety of
chemical agents, generates the irritation and itching and
can lead to severe contact dermatitis. The contact der-
matitis provoked by chemical agents, such as picryl
chloride (PC) and 2,4-dinitrofluorobenzene (DNFB), is an
inflammatory disorder generated in the local skin. In
contact dermatitis, the proliferation of keratinocytes and
marked infiltration of inflammatory cells, including
neutrophils, monocytes and lymphocytes, to the skin are
observed.1 In addition, there is some evidence to indicate
that various kinds of cytokines including interleukin (IL)-4,
interferon (IFN)-g , IL-6 and IL-1 play crucial roles for 
the initiation and progression of contact dermatitis.2–5
Among these cytokines, the importance of IFN-g in the
elicitation and progression of contact dermatitis has
been verified using IFN-g -overexpressing mice and IFN-g
receptor-deficient mice.6,7 Carroll et al. have reported
that IFN-g transgenic mice show an augmentation of
contact hypersensitivity to topical application of DNFB,
compared with wild-type mice.6 Saulnier et al. have
reported that dermal infiltration of mononuclear cells
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and epidermal microabscesses induced by the 2,4,6-
trinitrochlorobenzene (TNCB) is diminished in IFN-g
receptor-deficient mice.7 In addition to this evidence,
some reports have shown that retinoids regulate trans-
cription of cytokines such as IL-6 and IFN-g .8,9 Cippitelli
et al. have demonstrated that retinoic acid inhibits IFN-g
gene expression through the down-modulation of activa-
tion of the IFN-g promoter.8
Retinoid is a potent ligand for retinoic acid receptors
(RAR), which belong to the steroid/thyroid receptor super-
family.10 Three RAR subtypes, including a , b and g , 
have been identified.11 The retinoid-RAR complex elicits
a variety of biological activities, such as the regulation of
cell growth,12 differentiation13 and anti-angiogenesis,14
through the regulation of transcription of various genes
either by activating the expression of genes, including
RAR-responsive elements (RARE) in the promoter regions,15
or by inhibiting expression of some genes by antagoniz-
ing AP-1-mediated gene expression.16
In a previous study, a novel synthetic retinoid, 4-((5,6,
7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carba-
moyl) benzoic acid (Am-80) showed an inhibitory effect
on collagen-induced arthritis in mice, which is an auto-
immune disease model, by inhibiting the production of
pro-inflammatory cytokines at the transcriptional level.9
Am-80 has approximately 10-fold more potent bio-
logical activity than all-trans-retinoic acid by binding to
the RARa and RARb , but not RARg . Am-80 has superior
properties, including stability to light, heat and oxidation
and less toxicity and resistance than all-trans-retinoids.
These findings suggest that Am-80 may inhibit contact
dermatitis. Previously, a mouse model generating severe
contact hypersensitivity17 was established. In this model,
mice receiving repeated paintings of DNFB to their ears
showed severe dermatitis, together with marked infil-
tration of inflammatory cells including neutrophils,
mononuclear cells and eosinophils, increased hapten-
specific IgE in serum and excess expression of mRNA for
IFN-g and IL-4 in cervical lymph nodes.
In the present study, Am-80 is shown to potently inhibit
contact dermatitis induced by repeated applications of
DNFB through inhibition of the inflammatory cytokines,
especially IFN-g .
METHODS
Animals
Female C57BL/6 mice of the age of 6 weeks, obtained
from Japan SLC Inc. (Hamamatsu, Japan), were housed
in plastic cages in an air-conditioned room at 24°C, fed
a standard laboratory diet and allowed free access to
water. All experiments were carried out following the
guidelines for the care and use of experimental animals
of the Japanese Association for Laboratory Animal
Science of 1987.18
Reagents
The Am-80 was synthesized as described previously.9
The Am-80 was suspended in 0.5% carboxymethyl cel-
lulose (CMC) solution for oral administration.
Monoclonal anti-dinitrophenyl (DNP) IgE antibody
(Clone SPE-7; Sigma Chemical Co., St Louis, MO, 
USA), peroxidase-conjugated streptavidin (Dakopatts
a/s, Glostrup, Denmark), bovine serum albumin (BSA
for ELISA grade; Sigma Chemical Co.), DNP-BSA (LSL
Co. Ltd, Tokyo, Japan), NHS-LC-Biotinylation kit (Pierce
Chemical Co., Rockford, IL, USA), substrate kit (Sumi-
tomo Bakelite Co. Ltd, Tokyo, Japan), ISOGEN (Nippon
Gene Co. Ltd, Tokyo, Japan), reverse transcriptase poly-
merase chain reaction (RT-PCR) primer sets ( b -actin,
IFN- g , IL-1, IL-4; Stratagene Co. Ltd, La Jolla, CA, USA),
1st-STRANDED TM cDNA Synthesis kit (Clontech Lab.
Inc., Palo Alto, CA, USA) and PCR Reagents Kit (Perkin
Elmer Japan Co. Ltd, Urayasu, Japan) were purchased
from listed suppliers.
Induction of DNFB-induced contact
hypersensitivity
Ears of mice were painted with 25 m L 0.15% DNFB in
vehicle (acetone:olive oil = 3:1) or vehicle alone applied
to each side of the ear once a week. Ear thickness was
measured at various time points after applying DNFB
using an engineering micrometer (R1-A, Ozaki MFG Co.
Ltd, Tokyo, Japan) and is expressed as the increase in
thickness from that at time 0. The Am-80 suspended in
CMC was orally administered once per day throughout
the experiment from the first sensitization with DNFB.
Histopathologic study of skin lesion
Mice ears were removed 24 h after the fifth painting with
vehicle or DNFB and fixed with 10% neutral formalin.
Ears were then cut into parasagittal slices, dehydrated
and embedded in paraffin according to the standard pro-
cedures. Paraffin sections were stained with hematoxylin
and eosin, then assessed under a light microscope.
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Measurement of hapten specific IgE
concentration in mice sera
To measure anti-DNP IgE levels in serum, sera were
obtained from the mice 24 h after the fifth painting 
with DNFB. The anti-DNP IgE in mice sera were mea-
sured using the enzyme-linked immunosorbent assay
(ELISA) described below.
The immunoplate (Maxisorp Nunc-Immuno Plate,
Nalge Nunc International, Tokyo, Japan) was coated with
monoclonal antimouse IgE antibody and incubated at
4°C overnight. To decrease the non-specific reaction 
of antibodies, the immunoplate was treated with 
phosphate-buffered saline (PBS) containing 1% BSA,
incubated at room temperature for 1 h and washed three
times with PBS containing 0.2% Tween 20 (T-PBS).
Monoclonal anti-DNP IgE antibody was sequentially
diluted as the standard. Diluted serum samples at a
volume of 100 m L were added to each well and the 
plates were incubated at room temperature for 1 h. After
washing with T-PBS, 100 m L diluted biotinylated DNP-
BSA was added to each well and incubated at room tem-
perature for 1 h. After extensive washing with T-PBS, 100
m L diluted peroxidase-conjugated streptavidin was added
to each well. The enzymatic reaction was stopped by
adding 100 m L stop solution after incubation at room
temperature for 1 h. The optical density of the reaction
mixture was read using an automatic ELISA plate reader
(Titertek Multiscan MCC/340, Flow Laboratories Inc.) at
450 nm.
The anti-DNP IgE titers were expressed in ng/mL,
based on laboratory generated standards and appropri-
ate commercial standards.
Analysis of mRNA expression of cytokines in
mice cervical lymph nodes and ears by RT-PCR
Expression levels of mRNA for cytokines in cervical lymph
nodes of mice were assessed by the RT-PCR technique.
Using ISOGEN, total RNA was extracted from cervical
lymph nodes in mice at 4 h after the fifth treatment with
DNFB.
The total RNA (500 ng) was reverse-transcribed with
the 1st-STRANDED TM cDNA Synthesis Kit at 42°C for 
60 min, 94°C for 5 min and then soaked at 5°C for 5 min.
The PCR was performed under standard conditions as
follows: (i) 5 min at 94°C for 1 cycle; (ii) 1 min 30 s at
94°C , 1 min 30 s at 60°C and 1 min 30 s at 72°C for 
30 or 35 cycles; (iii) 10 min at 72°C for 1 cycle; and (iv)
5 min at 5°C.
Primer sets used for the amplification of first-strand
cDNA were as follows: IFN-g , 5¢ -TACTGCCACG-
GCACAGTCATTGAA-3 ¢ , 5¢ -GCAGCGACTCCTTTTCC-
GCTTCCT-3¢ ; IL-1- b , 5¢ -CAGGATGAGGACATGAG-
CACC-3 ¢ , 5¢ -CTCTGCAGACTCAAACTCCAC-3 ¢ ; IL-4,
5¢ -ACGGAGATGGATGTGCCAAACGTC-3 ¢ , 5¢ -CGAG-
TAATCCATTTGCATGATGC-3 ¢ ; and b -actin, 5¢ -GTGG-
GCCGCTAGGCACCA-3¢ , 5¢ -CGGTTGGCCTTAGG-
GTTCAGGGGGG-3 ¢ . The PCR products were resolved
by electrophoresis and stained with ethidium bromide to
reveal the amplified cDNA.
Statistics
Results are expressed as the mean ± SEM. One-way
ANOVA/Dunnett’s post hoc procedure was used to assess
the significance of results. P < 0.05 was considered to
be statistically significant.
RESULTS
Effect of Am-80 on the contact dermatitis
generated by repeated applications of DNFB
The ears of mice painted with 0.15% DNFB, but not with
vehicle alone, provoked severe contact dermatitis in pro-
portion to the number of DNFB applications. Ear swelling
was increased at approximately 1 h and reached a peak
at 24 h after painting with DNFB (Fig. 1a). The Am-80
was administrated at the dosage of 0.3–3.0 mg/kg per
day orally once per day throughout the experiment after
the first sensitization with DNFB. The Am-80 significantly
inhibited ear swelling 1 h and 24 h after the fifth painting
with DNFB, in a dose-dependent manner (Fig. 1b).
Throughout this experiment, conspicuous adverse effects,
such as loss of weight, were not observed in mice treated
with Am-80 (data not shown).
In the histopathologic study, marked infiltration of cells
such as neutrophils, lymphocytes and monocytes were
elicited in the ears of mice treated with 0.15% DNFB, but
not with vehicle alone. In the ears of mice administered
Am-80 at the dosage of 3.0 mg/kg per day, infiltration of
cells was clearly reduced (Fig. 2).
Effect of Am-80 on the production of 
anti-DNP IgE at the transcriptional and
post-transcriptional levels
We investigated the effect of Am-80 on the production of
anti-DNP IgE in sera. The sera were obtained from mice
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24 h after the fifth painting with DNFB. The amounts of
anti-DNP IgE were measured using the ELISA technique.
The serum level of anti-DNP IgE was significantly ele-
vated in mice treated with 0.15% DNFB, but not with
vehicle alone, in proportion to the number of DNFB
applications (data not shown). As shown in Fig. 3a, 
Am-80 did not affect the production of anti-DNP IgE 
even at the highest dosage (3.0 mg/kg per day, 
P = 0.563). In addition, the effect of Am-80 on the tran-
scriptional level of productive Ce in cervical lymph nodes
was examined. Cervical lymph nodes were isolated from
mice 4 h after the fifth treatment with DNFB and total
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Fig. 1 Effects of 4-((5,6,7,8-
tetrahydro-5,5,8,8-tetramethyl-2-
naphthyl) carbamoyl) benzoic acid
(Am-80) in the time course study
(a) and dose–response study (b) on
the contact dermatitis elicited by
repeated applications of 2,4-dini-
trofluorobenzene (DNFB). In the
dose–response study, the findings
after the fifth application of DNFB
are shown. The Am-80 was orally
administered once per day
throughout the experiment from
the first sensitization. Results are
represented as the mean ± SEM
of increased ear thickness from
that at time 0 (n = 6). (n), vehicle;
(d), DNFB; (s) Am-80 3.0 mg/kg
per day. *P < 0.05 was con-
sidered as statistically significant
compared with the control group.
Fig. 2 Effects of 4-((5,6,7,8-
tetrahydro-5,5,8,8-tetramethyl-2-
naphthyl) carbamoyl) benzoic acid
(Am-80) on histopathology. At 24 h
after the fifth application of 2,4-
dinitrofluorobenzene (DNFB), ears
of mice were isolated, fixed and
stained with hematoxylin and eosin.
The Am-80 was administered once
per day throughout the experiment
from the first application of DNFB.
(a) Vehicle, (b) DNFB, (c) DNFB +
Am-80 (3.0 mg/kg per day).
RNA was extracted and purified using ISOGEN. The expres-
sion level of productive Ce mRNA was assessed using the
RT-PCR technique. The Am-80 did not affect the expression
level of productive Ce mRNA in cervical lymph nodes 
(Fig. 3b). These findings suggested that Am-80 did not
affect the production of anti-DNP IgE at both the trans-
criptional and post-transcriptional levels; and that it in-
hibited the contact dermatitis at the post-sensitization phase.
Effect of Am-80 on expression levels of
cytokine mRNA in the cervical lymph nodes
of mice
In the preliminary experiment, the expression levels of
mRNA for these cytokines in the cervical lymph nodes of
DNFB-treated mice reached their peak and plateau 4–8 h
after DNFB-sensitization (data not shown). Therefore, the
effect of Am-80 on transcription levels of cytokines,
including IFN-g , IL-1 and IL-4, on the cervical lymph
nodes of mice at 4 h after the treatment with DNFB was
investigated. Expression levels of mRNA for all cytokines
was elevated in cervical lymph nodes of mice treated with
DNFB compared with mice treated with vehicle alone.
The Am-80 obviously diminished expression levels of
mRNA for IFN- g , but not for IL-1 and IL-4, in a dose-
dependent manner (Fig. 4).
DISCUSSION
Contact dermatitis is an allergic inflammatory skin
disease with marked infiltration of inflammatory cells. In
the present study, the effect of Am-80 on mouse contact
hypersensitivity due to repeated application of DNFB
to ears was investigated. In this model, severe elevation 
of ear swelling and serum anti-DNP IgE levels were
observed. Oral administration of Am-80 once per day
showed a potent and significant inhibition of the ear
swelling and histopathologic changes in the skin lesion.
However, Am-80 did not affect the serum level of anti-
DNP IgE and the expression level of productive Ce mRNA
in the cervical lymph node. Immunoglobulin E, following
the activation of mast cells, plays a crucial role in the ear
swelling response at early time points through the release
of a variety of chemical mediators, such as histamine,
serotonin and leukotrienes. In the present study, although
the serum level of anti-DNP IgE was elevated in parallel
with the increase of ear swelling, Am-80 inhibited an
increase in ear swelling at 1 h after treatment with DNFB,
despite no affect on the anti-DNP IgE level. This finding
suggests that Am-80 may inhibit the function of mast cells
at the post IgE–antigen interaction stage. In addition,
Geba et al. have reported the importance of serotonin
release from platelets during the early phase reaction of
contact hypersensitivity.19 To clarify the mechanism of how
Am-80 inhibits the early phase reaction of dermatitis with-
out inhibiting the production of IgE requires further studies.
Much attention has been paid to the role of cytokines in
the onset and development of allergic skin disease. Some
reports show the roles of IL-4,2 IFN-g 3 and IL-64 in contact
dermatitis. Among them, IFN-g especially contributes to the
initiation and progression of contact hypersensitivity.
Interferon-g , which is generated especially by T helper (Th)1
cells, induces various kinds of biologic events, such as the
elicitation of adhesion molecule expression, keratinocyte
EFFECT OF AM-80 ON CONTACT DERMATITIS 79
Fig. 3 Effects of 4-((5,6,7,8-tetrahydro-5,5,8,8-tetra-hydro-
5,5,8,8-tetra-methyl-2-naphthalenyl) carbamoyl) benzoic acid
(Am-80) on serum levels of anti-dinitrophenyl (DNP) IgE. Mice
sera were isolated 24 h after the fifth application of 2,4-dinitro-
fluorobenzene (DNFB). Quantities of anti-DNP IgE in sera were
assessed using the enzyme-linked immunosorbent assay tech-
nique. Results are represented as the mean ± SEM of six
samples. The Am-80 was administered once per day through-
out the experiment from the first application of DNFB. (b) Lane
1, vehicle; lane 2, DNFB; lanes 3–5, DNFB + Am-80 at 0.3
(lane 3), 1.0 (lane 4) or 3.0 (lane 5) mg/kg per day.
proliferation and down-regulation of Th2-type cytokines.20
Some studies have also shown the functional role of IFN- g
in contact dermatitis. Carroll et al. have reported an aug-
mentation of contact dermatitis in IFN- g transgenic mice.6
Furthermore, Saulnier et al. have reported an abrogation
of dermal infiltration of mononuclear cells and epidermal
microabscesses in IFN-g receptor-deficient mice.7 In the
present study, Am-80 clearly decreased the expression
level of mRNA for IFN-g , but not for IL-1 and IL-4, in
cervical lymph nodes of DNFB-sensitized mice. Cippitelli et
al. have also reported that retinoic acid diminishes the
expression level of the IFN-g gene through down-modula-
tion of the IFN-g promoter.8 Their findings support those of
the present study. In the histopathologic study of the mouse
ear, the marked reduction in inflammatory cell infiltration
by Am-80 may have been due to the suppression of adhe-
sion molecules by the inhibition of IFN- g production.
However, in contact hypersensitivity many kinds of cyto-
kines are involved in the initiation and development of the
reaction and the cytokine network is complicated. There-
fore, further studies will be necessary to clarify this point.
In conclusion, it has been demonstrated that Am-80
potently inhibits the contact dermatitis caused by re-
peated applications of DNFB, probably through the
depression of IFN-g mRNA. Hence, Am-80 may be useful
for treatment of contact dermatitis. For the clinical trial,
however, further studies, such as investigating the effect
of Am-80 in mice chronically inducing contact hyper-
sensitivity, will be necessary.
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